This could be associated with a higher risk for false-positive findings since recent studies revealed a crucial role of LAT1 in activated T cells and reported overexpression of the LAT1 in inflammation, while LAT2 is more tumor-selective [57]. Here, LAT2 is linked to neoplasm.